Vitreous Incarceration After Ranibizumab Injection: An Ultrasound Biomicroscopy Study
[ N/A ]
Tarih
2015
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Yayıncı
Slack Inc
Erişim Hakkı
info:eu-repo/semantics/closedAccess
Özet
BACKGROUND AND OBJECTIVE: The aim of the study was to evaluate vitreous incarceration at the injection site using ultrasound biomicroscopy (UBM) after intravitreal injection of ranibizumab. PATIENTS AND METHODS: The study included 39 eyes of 34 patients who underwent intravitreal injection of 0.05 mL of ranibizumab. UBM (HiScan; Optikon, Rome, Italy) with a 50 MHz probe was performed 1 day after surgery to determine the existence of vitreous incarceration at the injection site. RESULTS: The mean patient age was 59.7 (+/- 10.1) years, and 58.9% were female. Vitreous incarceration into the pars plana site was detected in six eyes (15.3%) the day after intravitreal injection. CONCLUSION: Vitreous incarceration at the injection site after intravitreal injection is thought to lead to a higher risk for complications such as infection, retinal breaks, retinal detachment, vitreous hemorrhage, and fibrovascular proliferation at the injection site. To understand the clinical importance of vitreous incarceration, further long-term prospective studies are necessary.
Açıklama
Anahtar Kelimeler
Pars-Plana Vitrectomy, Intraocular-Pressure Changes, Intravitreal Triamcinolone Acetonide, Sclerotomy Sites, 25-Gauge Vitrectomy, Macular Degeneration, Hemorrhage, Bevacizumab, Lucentis, Retina
Kaynak
Ophthalmic Surgery Lasers & Imaging Retina
WoS Q Değeri
Q3
Scopus Q Değeri
Q3
Cilt
46
Sayı
4
